| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |